A Rapid Cardiovascular Magnetic Resonance Assessment for Cancer Therapy-Related Cardiac Dysfunction Supports the Routine Incorporation of Cardiovascular Magnetic Resonance into Cardio-Oncology Care

Am J Cardiol. 2023 Nov 1:206:330-331. doi: 10.1016/j.amjcard.2023.09.015. Epub 2023 Sep 22.

Author

W Patricia Bandettini¹

Affiliation

¹ National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: ingkanisorn@nih.gov.

PMID: 37743145
DOI: 10.1016/j.amjcard.2023.09.015

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents* / adverse effects
Cardiotoxicity / etiology
Cardiovascular Diseases* / therapy
Heart
Heart Diseases*
Humans
Magnetic Resonance Spectroscopy
Medical Oncology
Neoplasms* / drug therapy

Substances

Antineoplastic Agents